Search results for "Therapeutic approach"

showing 10 items of 80 documents

Third-line therapy for advanced non-small-cell lung cancer patients: a feasible therapeutic option?

2010

Two decades ago best supportive care was considered a valid therapeutic option for advanced non-small cell lung cancer (NSCLC) patients until the evidence derived from meta-analysis showed symptom improvement and a survival advantage from systemic chemotherapy. A further advantage was reported when docetaxel and pemetrexed were used as second-line treatment after failure of first-line platinum-based chemotherapy. Furthermore, the biologic therapies targeting the epidermal growth factor receptor – erlotinib and gefitinib – have modified the therapeutic approach to second- and third-line treatment of NSCLC patients. In fact, to date, erlotinib is the only drug to be licensed for third-line th…

OncologyCancer Researchmedicine.medical_specialtyLung NeoplasmsTherapeutic approachGefitinibInternal medicineCarcinoma Non-Small-Cell LungAntineoplastic Combined Chemotherapy ProtocolsmedicineBiomarkers TumorHumansEpidermal growth factor receptorLung cancerneoplasmsClinical Trials as Topicbiologybusiness.industryCancerGeneral Medicinemedicine.diseasePrognosisrespiratory tract diseasesSurgeryPemetrexedOncologyDocetaxelbiology.proteinErlotinibbusinessmedicine.drugOncology
researchProduct

Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models

2018

Patient-derived xenograft (PDX) models have become an important asset in translational cancer research. However, to provide a robust preclinical platform, PDXs need to accommodate the tumor heterogeneity that is observed in patients. Colorectal cancer (CRC) can be stratified into four consensus molecular subtypes (CMS) with distinct biological and clinical features. Surprisingly, using a set of CRC patients, we revealed the partial representation of tumor heterogeneity in PDX models. The epithelial subtypes, the largest subgroups of CRC subtype, were very ineffective in establishing PDXs, indicating the need for further optimization to develop an effective personalized therapeutic approach …

OncologyCancer Researchmedicine.medical_specialtyPartial representationColorectal cancerbusiness.industryTumor cellsmedicine.diseaseTumor heterogeneityTumor Subtype03 medical and health sciencesTherapeutic approach0302 clinical medicineOncology030220 oncology & carcinogenesisInternal medicinemedicineIn patientbusinessInternational Journal of Cancer
researchProduct

Osteonecrosis of the jaw induced by receptor activator of nuclear factor-kappa B ligand (Denosumab) - Review.

2015

Background Denosumab, an anti-resorptive agent, IgG2 monoclonal antibody for human Receptor activator of nuclear factor-kappa B ligand (RANKL), has been related to the occurrence of osteonecrosis of the jaws. Thus, the aim of this study was to review the literature from clinical case reports, regarding the type of patient and the therapeutic approach used for osteonecrosis of the jaws induced by chronic use of Denosumab. Material and Methods For this, a literature review was performed on PubMed, Medline and Cochrane databases, using the keywords “Denosumab” “anti-RANK ligand” and “Osteonecrosis of jaw”. To be included, articles should be a report or a serie of clinical cases, describing pat…

OncologyMalemedicine.medical_specialtyOsteoporosisOdontologíaReview03 medical and health sciencesTherapeutic approachProstate cancer0302 clinical medicineDiabetes mellitusInternal medicinemedicineHumansGeneral DentistryAgedBisphosphonate-associated osteonecrosis of the jawOral Medicine and PathologybiologyBone Density Conservation AgentsDiphosphonatesbusiness.industryRANK LigandNF-kappa BOsteonecrosis030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludSurgeryDenosumabOtorhinolaryngologyRANKL030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASbiology.proteinSurgeryBisphosphonate-Associated Osteonecrosis of the JawFemaleDenosumabbusinessOsteonecrosis of the jawmedicine.drugMedicina oral, patologia oral y cirugia bucal
researchProduct

Rituximab in primary Sjögren's syndrome: a ten-year journey

2014

Primary Sjögren's syndrome (pSS) is an autoimmune disorder affecting exocrine glands and characterized in most cases by a rather mild clinical picture. However, a subgroup of pSS patients experience systemic extraglandular involvement leading to a worsening of disease prognosis. Current therapeutic options for the treatment of pSS are mainly empirical, often translated by other autoimmune diseases, and recent systematic reviews have highlighted the lack of evidence-based recommendations for most of the drugs commonly employed in the spectrum of extraglandular involvement. Because of the well-established role of B-lymphocytes in the pathogenesis of pSS, a B-cell targeting therapy may repres…

Oncologymedicine.medical_specialtySjogren's syndrome RituximabContext (language use)DiseasePathogenesisAntibodies Monoclonal Murine-DerivedTherapeutic approachRheumatologyInternal medicinemedicineHumansImmunologic FactorsLymphocyte CountClinical efficacyB-Lymphocytesbusiness.industrystomatognathic diseasesSystematic reviewSjogren's syndromeImmunologyRituximabSjogren sbusinessRituximabmedicine.drug
researchProduct

The neurochemistry of autism

2020

Autism spectrum disorder (ASD) refers to complex neurobehavioral and neurodevelopmental conditions characterized by impaired social interaction and communication, restricted and repetitive patterns of behavior or interests, and altered sensory processing. Environmental, immunological, genetic, and epigenetic factors are implicated in the pathophysiology of autism and provoke the occurrence of neuroanatomical and neurochemical events relatively early in the development of the central nervous system. Many neurochemical pathways are involved in determining ASD; however, how these complex networks interact and cause the onset of the core symptoms of autism remains unclear. Further studies on ne…

OpinionSerotoninN-acetyl aspartateSensory processingmedicine.medical_treatmentDopamineOxytocinlcsh:RC321-57103 medical and health sciencesTherapeutic approachGABA0302 clinical medicineNeurochemicalmental disordersmedicineNeurochemistryAutism spectrum disorderlcsh:Neurosciences. Biological psychiatry. Neuropsychiatry030304 developmental biologyEndogenous opioidMelatonin0303 health sciencesbusiness.industryGeneral NeuroscienceGlutamate receptorNeurochemistrymedicine.diseaseAcetylcholineAutism spectrum disorderAutismGlutamatebusinessNeuroscience030217 neurology & neurosurgery
researchProduct

Painful scar neuropathy: principles of diagnosis and treatment

2015

Nerve-tissue interactions are critical. Peripheral nerve injuries may involve intraneural and extraneural scar formation and affect nerve gliding planes, sometimes leading to complex clinical presentations. All of these pathological entities involve pain as the main clinical symptom and can be subsumed under the term "painful scar neuropathy". The authors review the literature on treatment approaches to peripheral nerve scar neuropathy and the outcomes of neurolysis-associated procedures and propose a simple classification and a therapeutic approach to scar neuropathy. The search retrieved twenty-one papers, twenty of which reported pain reduction or resolution with various techniques. Ther…

Painful scarLesion typemedicine.medical_specialtybusiness.industrySettore MED/19 - Chirurgia PlasticaLogical approachExtraneuralComplex regional pain syndrome type II painful neuropathy painful scar neuropathy scar neuritis traction neuropathySurgeryTherapeutic approachPeripheral nerveNeuropathic painMedicinebusinessPathological
researchProduct

Microsatellite Instability in Colorectal Cancer: Time to Stop Hiding!

2011

Colorectal cancer (CRC) is the second cause of cancer-related death worldwide. Surgery constitutes the primary therapy for these tumors, together with chemotherapy that is usually recommended in patients with metastatic primary CRC. Although molecularly distinct entities arising from different physiopathogenic mechanisms - microsatellite (MSI) and chromosomal instability (also called microsatellite stable, MSS) - have been characterized in CRC, there is still no specific therapeutic approach that takes into account disease’s molecular heterogeneity [1]. MSI is observed in 1015% of sporadic CRCs. MSI CRCs displayed particular morphologic features, with greater predilection for the right colo…

Pathologymedicine.medical_specialtyChemotherapyColorectal cancermedicine.medical_treatmentMicrosatellite instabilityDiseaseBiologymedicine.diseasedigestive system diseasesTherapeutic approachOncologyChromosome instabilityCancer researchmedicineMicrosatelliteAnimalsHumansIn patientMicrosatellite InstabilityHSP110 Heat-Shock ProteinsColorectal NeoplasmsneoplasmsEditorial CommentsOncotarget
researchProduct

Outcomes of Diabetic Retinopathy Post-Bariatric Surgery in Patients with Type 2 Diabetes Mellitus

2021

Bariatric surgery is an emerging therapeutic approach for obese type 2 diabetes mellitus (T2DM) patients, with proven benefits for achieving target glucose control and even remission of diabetes. However, the effect of bariatric surgery upon diabetic retinopathy is still a subject of debate as some studies show a positive effect while others raise concerns about potential early worsening effects. We performed a systematic review, on PubMed, Science Direct, and Web of Science databases regarding the onset and progression of diabetic retinopathy in obese T2DM patients who underwent weight-loss surgical procedures. A total of 6375 T2DM patients were analyzed. Most cases remained stable after b…

Pediatricsmedicine.medical_specialtyPost bariatric surgeryendocrine system diseasesbusiness.industrytype 2 diabetes mellitusbariatric surgeryRType 2 Diabetes MellitusReviewGeneral MedicineDiabetic retinopathymedicine.diseaselaw.inventionTherapeutic approachdiabetic retinopathyBlood pressureRandomized controlled triallawDiabetes mellitusmedicineMedicineIn patientprogressionbusinessJournal of Clinical Medicine
researchProduct

Editorial: Management of Elevated Heart Rate in Essential Hypertension: Pathophysiological Insights and Therapeutic Approach.

2017

Pharmacologybusiness.industryPhysical activityPhysical activityDisease ManagementBlood PressureBioinformaticsEssential hypertensionmedicine.diseasePathophysiologyElevated heart rateTherapeutic approachHeart RateDrug DiscoveryMedicineAnimalsHumansEssential HypertensionbusinessCurrent pharmaceutical design
researchProduct

Quercetin and MicroRNA Interplay in Apoptosis Regulation in Ovarian Cancer

2020

The multifaceted nature of ovarian cancer has severely hampered the development of effective therapeutics over the years. The complicate nature of ovarian cancer makes it therapeutically challenging, therefore, there has been a renewed interest in phytochemistry. Phytochemicals have emerged as a potential therapeutic option due to less side effects. Moreover, the signaling inhibition properties have also been studied extensively in recent times. A growing number of data obtained via high-throughput technologies has started to delineate the complex oncogenic signaling networks, thus broadening the therapeutic opportunities. Within the network, microRNAs (miRNAs) have been shown to play a ve…

PhytochemicalsApoptosisCarcinoma Ovarian EpithelialBiologyTherapeutic approachchemistry.chemical_compoundOvarian cancerDrug DiscoveryOncogenic signalingmicroRNAmedicineHumansSettore BIO/06 - Anatomia Comparata E CitologiaCytotoxicityOvarian NeoplasmsPharmacologyChemo-preventive agentCancermedicine.diseaseMicroRNAschemistryApoptosismiRNAsCancer researchFemaleQuercetinOvarian cancerQuercetin
researchProduct